Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.55% | 73.74 | 0.9% | $598.99m | |
| CELG | Celgene Corporation | -0.84% | 129.19 | 1.1% | $425.21m | |
| AMGN | Amgen Inc. | -0.63% | 169.00 | 1.1% | $397.19m | |
| BIIB | Biogen Inc. | -1.42% | 282.64 | 1.2% | $346.45m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.31% | 477.15 | 2.7% | $319.17m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.43% | 153.25 | 1.9% | $227.49m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.83% | 135.67 | 1.9% | $211.59m | |
| ILMN | Illumina, Inc. | -0.59% | 193.62 | 3.5% | $208.34m | |
| KITE | Kite Pharma, Inc. | 1.63% | 138.17 | 16.1% | $135.10m | |
| INCY | Incyte Corporation | -0.17% | 123.65 | 2.6% | $130.04m | |
| CLVS | Clovis Oncology, Inc. | -0.68% | 71.61 | 18.0% | $125.25m | |
| TSRO | TESARO, Inc. | -0.18% | 120.40 | 14.7% | $124.85m | |
| A | Agilent Technologies, Inc. | -0.30% | 62.77 | 1.5% | $122.45m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.07% | 81.40 | 4.4% | $105.16m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.38% | 36.07 | 19.8% | $88.80m |
Company Profile
Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.